VALBIOTIS (EPA:ALVAL) | WebDisclosure

PRESS RELEASE

published on 01/29/2024 at 17:40, 9 months 22 days ago

Valbiotis publie son calendrier financier de l’exercice 2024
Valbiotis publie son calendrier financier pour l'exercice 2024 avec les dates de publication du rapport annuel 2023, de l'assemblée générale annuelle et du rapport semestriel 2024

Calendrier Financier Valbiotis Exercice 2024 Compléments Alimentaires Innovation Scientifique
PRESS RELEASE

published on 01/29/2024 at 17:40, 9 months 22 days ago

Valbiotis presents its 2024 financial communication calendar
Valbiotis presents its 2024 financial communication calendar. The company specializing in dietary supplements announces publication dates for the 2023 annual report and 2024 half-year report, as well as the Annual General Meeting

Financial Communication Calendar Valbiotis Dietary Supplements Metabolic Diseases Cardiovascular Diseases
PRESS RELEASE

published on 11/07/2023 at 17:40, 1 year ago

Valbiotis annonce le succès de l’étude clinique de mode d’action sur TOTUM•63, contre le prédiabète et les stades précoces du diabète de type 2
PRESS RELEASE

published on 11/07/2023 at 17:40, 1 year ago

Valbiotis announces the success of the TOTUM•63 mode of action clinical study, against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE

published on 11/06/2023 at 17:40, 1 year ago

Valbiotis : Déclaration mensuelle du nombre d’actions et droits de vote – Octobre 2023
PRESS RELEASE

published on 10/04/2023 at 17:40, 1 year 1 month ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
PRESS RELEASE

published on 10/02/2023 at 17:40, 1 year 1 month ago

VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
PRESS RELEASE

published on 10/02/2023 at 17:40, 1 year 1 month ago

VALBIOTIS SA : l’étude de Phase II/III REVERSE-IT sélectionnée pour une présentation orale au congrès 2023 de l’EASD, principale société savante européenne pour le diabète
PRESS RELEASE

published on 09/28/2023 at 17:40, 1 year 1 month ago

Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
PRESS RELEASE

published on 09/28/2023 at 17:40, 1 year 1 month ago

Valbiotis publie son rapport financier pour le premier semestre 2023 et confirme sa feuille de route stratégique

Published on 11/21/2024 at 16:30, 1 hour 6 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 35 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 36 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 36 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 36 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 17:06, 30 minutes ago

Original-Research: PORR AG (von Montega AG): Kaufen
Published on 11/21/2024 at 17:02, 34 minutes ago

Original-Research: SBF AG (von Montega AG): Kaufen
Published on 11/21/2024 at 17:01, 35 minutes ago

Original-Research: Delticom AG (von Montega AG): Kaufen
Published on 11/21/2024 at 16:00, 1 hour 36 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 54 minutes ago

Edison issues report on Murray Income Trust (MUT)

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 38 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 38 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 10 hours 38 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 21 hours 29 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 22 hours 16 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE

News